rs727504763
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PVS1PM2PP5
The NM_001134363.3(RBM20):c.3261_3262delinsG(p.Ser1087ArgfsTer17) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 32)
Consequence
RBM20
NM_001134363.3 frameshift
NM_001134363.3 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.0640
Genes affected
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 11 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 10-110821880-CC-G is Pathogenic according to our data. Variant chr10-110821880-CC-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 179284.We mark this variant Likely_pathogenic, oryginal submissions are: {Likely_pathogenic=2, Uncertain_significance=3}.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RBM20 | NM_001134363.3 | c.3261_3262delinsG | p.Ser1087ArgfsTer17 | frameshift_variant | 11/14 | ENST00000369519.4 | NP_001127835.2 | |
RBM20 | XM_017016103.3 | c.3096_3097delinsG | p.Ser1032ArgfsTer17 | frameshift_variant | 11/14 | XP_016871592.1 | ||
RBM20 | XM_017016104.3 | c.2877_2878delinsG | p.Ser959ArgfsTer17 | frameshift_variant | 11/14 | XP_016871593.1 | ||
RBM20 | XM_047425116.1 | c.2877_2878delinsG | p.Ser959ArgfsTer17 | frameshift_variant | 11/14 | XP_047281072.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RBM20 | ENST00000369519.4 | c.3261_3262delinsG | p.Ser1087ArgfsTer17 | frameshift_variant | 11/14 | 1 | NM_001134363.3 | ENSP00000358532 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:2Uncertain:3
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Pathogenic:1Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Aug 30, 2019 | Has not been previously published as pathogenic or benign to our knowledge; Not observed in large population cohorts (Lek et al., 2016); Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is not a known mechanism of disease; The majority of RBM20 variants reported in HGMD in association with cardiomyopathy are missense variants (Stenson et al., 2014); This variant is associated with the following publications: (PMID: 20590677, 19712804, 22004663) - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute | Feb 23, 2017 | - - |
Primary dilated cardiomyopathy Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 23, 2017 | The p.Ser1087fs variant in RBM20 has been reported by our laboratory in 2 indivi duals with DCM and segregated with disease in 4 affected relatives from 1 family . This variant was absent from large population studies, though the ability of t hese studies to accurately detect indels may be limited. This variant is predict ed to cause a frameshift, which alters the protein?s amino acid sequence beginni ng at position 1087 and leads to a premature termination codon 17 amino acids do wnstream. This alteration is then predicted to lead to a truncated or absent pro tein. In summary, although additional studies are required to fully establish it s clinical significance, the p.Ser1087fs variant is likely pathogenic. - |
Cardiomyopathy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario | Jan 12, 2023 | - - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 28, 2021 | The c.3261_3262delCCinsG variant, located in coding exon 11 of the RBM20 gene, results from the deletion of two nucleotides and insertion of one nucleotide causing a translational frameshift with a predicted alternate stop codon (p.S1087Rfs*17). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. However, loss of function of RBM20 has not been clearly established as a mechanism of disease. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at